HP Adhesives (HPAL)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Negligible debt (D/E 0.01) provides financial flexibility and safety
• Promoter holding of 71.35% aligns management interests with minority shareholders
• ROCE of 13.57% is respectable and above the cost of capital
• Book value of ₹19.08 and a 52-week low of ₹26.52 offer a rough downside reference

Concerns

• P/E of 24.22 is expensive given a 55.05% profit decline and negative sales growth of -1.42%
• Latest quarter net profit of only ₹2 Cr on ₹65 Cr sales implies a fragile ~3% margin
• Piotroski F-score of 3/9 signals deteriorating financial health
• ROE of 7.61% is weak, indicating poor shareholder value creation at the current price

AI Analysis

Friends, when I look at HP Adhesives, I first check for a moat and consistent earning power. This is a specialty chemical company, but the numbers do not scream durable competitive advantage. Sales have actually contracted by 1.42% and profits have collapsed by 55.05%. A 24.22 P/E on such earnings decline is not an investment; it is optimism. The latest quarter tells the same story: ₹65 crore sales produced just ₹2 crore net profit, a thin margin that leaves no margin of safety. Graham would say price is what you pay, value is what you get. At ₹39.57, paying 2.07 times book value for a business earning 7.61% on equity is rich. Yes, the balance sheet is clean with debt-equity of only 0.01 and ROCE of 13.57% is respectable. A 71.35% promoter holding shows skin in the game. But what good is ownership alignment if the business is shrinking? The Piotroski F-score of 3 out of 9 is a red flag—it suggests deteriorating fundamentals. I would not call this a fast grower or a stalwart. It looks like a slow grower at best, possibly a turnaround only if management can arrest the decline. For an Indian retail investor, the dividend yield of 1.09% offers little compensation while waiting. I need evidence of returning sales growth, margin stability, and improved returns on capital before I deploy my rupees. Remember: it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. Here, I see a fair-to-weak business at an unwonderful price. Patience is the friend of the investor; today, I would watch and wait.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer